Hinova Pharmaceuticals Inc. (SHA:688302)
42.60
+1.98 (4.87%)
At close: Mar 6, 2026
15.60% (1Y)
| Market Cap | 4.22B +45.0% |
| Revenue (ttm) | 20.67M +5,535.7% |
| Net Income | -136.69M |
| EPS | -1.38 |
| Shares Out | 99.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,462,695 |
| Average Volume | 1,044,124 |
| Open | 40.29 |
| Previous Close | 40.62 |
| Day's Range | 40.29 - 42.68 |
| 52-Week Range | 31.10 - 71.98 |
| Beta | -0.08 |
| RSI | 38.10 |
| Earnings Date | Apr 25, 2026 |